Skip to main content
. 2021 Jan 8;12(1):76. doi: 10.3390/genes12010076

Table 3.

Injury incidence, distribution of athletes according to the number of injuries, and distribution of injuries according to severity, exposure, recurrence, mode of onset, and possible cause in elite endurance runners with different ACTN3 R577X genotypes.

Variable All RR RX XX p-Value
Incidence /per year 1.0 1.0 1.0 1.0 0.321
/1000 h or running 2.8 3.2 2.0 2.2 0.030
Number No injury (%) 36.0 39.5 31.4 37.5 0.177
1 injury (%) 31.5 21.1 40.0 37.5
2 injuries (%) 21.3 18.4 22.9 25.0
≥3 injuries (%) 11.2 21.1 5.7 0.0
Time loss Medical attention (%) 9.2 7.1 10.3 11.8 0.819
Time loss (%) 90.8 92.9 89.7 88.2
Severity Minor (%) 13.4 12.9 12.7 16.0 0.993
Moderate (%) 51.4 51.6 52.7 48.0
Serious (%) 35.2 35.5 34.5 36.0
Exposure Training (%) 94.9 95.3 94.9 94.1 0.981
Competition (%) 5.1 4.7 5.1 5.9
Recurrence New onset (%) 61.2 59.5 66.7 52.9 0.598
Recurrent (%) 38.8 40.5 33.3 47.1
Mode of onset Sudden (%) 46.9 45.2 43.6 58.8 0.552
Gradual (%) 53.1 54.8 56.4 41.2
Possible cause Excessive load (%) 62.2 61.9 61.5 64.7 0.526
Surface (%) 11.2 11.9 15.4 0.0
Shoe (%) 8.2 4.8 7.7 17.6
Biomechanics (%) 4.1 7.1 2.6 0.0
Unknown (%) 14.3 14.3 12.8 17.6

Data are frequencies (in percentage) from the total of injuries recorded in each genotype.